"10.1371_journal.pone.0040673","plos one","2012-07-16T00:00:00Z","Johanna Hol; Kari Otterdal; Unni M Breland; Espen Stang; Turid M Pedersen; Kathrine Hagelsteen; Trine Ranheim; Monika Kasprzycka; Bente Halvorsen; Guttorm Haraldsen; Pål Aukrust","Division of Pathology, Oslo University Hospital, Oslo, Norway; Research Institute for Internal Medicine, Oslo University Hospital, Oslo, Norway","Conceived and designed the experiments: JH KO UMB ES MK BH GH PA. Performed the experiments: JH KO UMB ES TMP MK KH. Analyzed the data: JH KO ES TR MK BH GH PA. Contributed reagents/materials/analysis tools: ES GH PA. Wrote the paper: JH GH PA. Critical revision of drafted manuscript and figures and approval of final result: JH KO UMB ES TMP TR MK KH BH GH PA.","The authors have read the journal’s policy and have the following conflicts: Pfizer (New York) contributed to the study by donating Ortho-hydroxy-atorvastatin. This does not alter the authors’ adherence to all the PLoS ONE policies on sharing data and materials. The authors have declared no other competing interests exist.","2012","07","Johanna Hol","JH",11,TRUE,8,7,8,3,TRUE,TRUE,FALSE,0,NA,FALSE
